Byler Disease Market Size, Share & Trends Analysis Report By Disease Type (PFIC1, PFIC2, PFIC3, Atypical PFIC), By Treatment Type (IBAT Inhibitors, Antipruritics, Rifampicin, Bile-acid Sequestrants, Nutritional/Supportive Therapy), By Distribution Channel (Hospital pharmacy;, Drug Stores & Retail Pharmacy, Online Pharmacy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 12, 2026 | Author: Straits Research Team | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Byler Disease Market Size Analysis
    1. Introduction
    2. Byler Disease Market Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
      1. PFIC1
      2. PFIC2
      3. PFIC3
      4. Atypical PFIC
    3. Byler Disease Market Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
      1. IBAT Inhibitors
      2. Antipruritics
      3. Rifampicin
      4. Bile-acid Sequestrants
      5. Nutritional/Supportive Therapy
    4. Byler Disease Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital pharmacy;
      2. Drug Stores & Retail Pharmacy
      3. Online Pharmacy
  7. North America Byler Disease Market Size Analysis
    1. Introduction
    2. Byler Disease Market Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
      1. PFIC1
      2. PFIC2
      3. PFIC3
      4. Atypical PFIC
    3. Byler Disease Market Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
      1. IBAT Inhibitors
      2. Antipruritics
      3. Rifampicin
      4. Bile-acid Sequestrants
      5. Nutritional/Supportive Therapy
    4. Byler Disease Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital pharmacy;
      2. Drug Stores & Retail Pharmacy
      3. Online Pharmacy
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
  8. Europe Byler Disease Market Size Analysis
    1. Introduction
    2. Byler Disease Market Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
      1. PFIC1
      2. PFIC2
      3. PFIC3
      4. Atypical PFIC
    3. Byler Disease Market Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
      1. IBAT Inhibitors
      2. Antipruritics
      3. Rifampicin
      4. Bile-acid Sequestrants
      5. Nutritional/Supportive Therapy
    4. Byler Disease Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital pharmacy;
      2. Drug Stores & Retail Pharmacy
      3. Online Pharmacy
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    7. France
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
  9. APAC Byler Disease Market Size Analysis
    1. Introduction
    2. Byler Disease Market Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
      1. PFIC1
      2. PFIC2
      3. PFIC3
      4. Atypical PFIC
    3. Byler Disease Market Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
      1. IBAT Inhibitors
      2. Antipruritics
      3. Rifampicin
      4. Bile-acid Sequestrants
      5. Nutritional/Supportive Therapy
    4. Byler Disease Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital pharmacy;
      2. Drug Stores & Retail Pharmacy
      3. Online Pharmacy
    5. China
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    8. India
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
  10. Middle East and Africa Byler Disease Market Size Analysis
    1. Introduction
    2. Byler Disease Market Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
      1. PFIC1
      2. PFIC2
      3. PFIC3
      4. Atypical PFIC
    3. Byler Disease Market Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
      1. IBAT Inhibitors
      2. Antipruritics
      3. Rifampicin
      4. Bile-acid Sequestrants
      5. Nutritional/Supportive Therapy
    4. Byler Disease Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital pharmacy;
      2. Drug Stores & Retail Pharmacy
      3. Online Pharmacy
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
  11. LATAM Byler Disease Market Size Analysis
    1. Introduction
    2. Byler Disease Market Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
      1. PFIC1
      2. PFIC2
      3. PFIC3
      4. Atypical PFIC
    3. Byler Disease Market Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
      1. IBAT Inhibitors
      2. Antipruritics
      3. Rifampicin
      4. Bile-acid Sequestrants
      5. Nutritional/Supportive Therapy
    4. Byler Disease Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital pharmacy;
      2. Drug Stores & Retail Pharmacy
      3. Online Pharmacy
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Disease Type 2025-2034 (USD MILLION/ Units)
        1. PFIC1
        2. PFIC2
        3. PFIC3
        4. Atypical PFIC
      3. Market Size & Forecast By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. IBAT Inhibitors
        2. Antipruritics
        3. Rifampicin
        4. Bile-acid Sequestrants
        5. Nutritional/Supportive Therapy
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacy;
        2. Drug Stores & Retail Pharmacy
        3. Online Pharmacy
  12. Competitive Landscape
    1. Byler Disease Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Ipsen (France)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Mirum Pharmaceuticals (US)
    3. GlaxoSmithKline (UK)
    4. Pfizer (US)
    5. Sanofi (France)
    6. Sandoz (Switzerland)
    7. Viatris (US)
    8. Teva Pharmaceutical Industries (Israel)
    9. Sun Pharmaceutical Industries (India)
    10. Lupin (India)
    11. Dr. Reddy’s Laboratories (India)
    12. Zydus Lifesciences (India)
    13. Cipla (India)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Byler Disease Market Size and Forecast By Regions - 2022-2034 (USD USD Billion)

Table 2: Global Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 3: Global Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 4: Global Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 5: North America Byler Disease Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 6: North America Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 7: North America Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 8: North America Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 9: U.S. Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 10: U.S. Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 11: U.S. Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 12: Canada Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 13: Canada Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 14: Canada Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 15: Europe Byler Disease Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 16: Europe Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 17: Europe Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 18: Europe Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 19: U.K. Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 20: U.K. Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 21: U.K. Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 22: Germany Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 23: Germany Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 24: Germany Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 25: France Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 26: France Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 27: France Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 28: Spain Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 29: Spain Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 30: Spain Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 31: Italy Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 32: Italy Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 33: Italy Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 34: Russia Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 35: Russia Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 36: Russia Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 37: Nordic Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 38: Nordic Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 39: Nordic Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 40: Benelux Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 41: Benelux Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 42: Benelux Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 43: Rest of Europe Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 44: Rest of Europe Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 45: Rest of Europe Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 46: APAC Byler Disease Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 47: APAC Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 48: APAC Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 49: APAC Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 50: China Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 51: China Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 52: China Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 53: Korea Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 54: Korea Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 55: Korea Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 56: Japan Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 57: Japan Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 58: Japan Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 59: India Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 60: India Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 61: India Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 62: Australia Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 63: Australia Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 64: Australia Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 65: Taiwan Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 66: Taiwan Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 67: Taiwan Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 68: South East Asia Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 69: South East Asia Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 70: South East Asia Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 71: Rest of Asia-Pacific Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 72: Rest of Asia-Pacific Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 73: Rest of Asia-Pacific Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 74: Middle East and Africa Byler Disease Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 75: Middle East and Africa Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 76: Middle East and Africa Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 77: Middle East and Africa Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 78: UAE Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 79: UAE Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 80: UAE Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 81: Turkey Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 82: Turkey Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 83: Turkey Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 84: Saudi Arabia Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 85: Saudi Arabia Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 86: Saudi Arabia Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 87: South Africa Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 88: South Africa Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 89: South Africa Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 90: Egypt Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 91: Egypt Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 92: Egypt Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 93: Nigeria Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 94: Nigeria Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 95: Nigeria Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 96: Rest of MEA Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 97: Rest of MEA Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 98: Rest of MEA Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 99: LATAM Byler Disease Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 100: LATAM Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 101: LATAM Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 102: LATAM Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 103: Brazil Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 104: Brazil Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 105: Brazil Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 106: Mexico Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 107: Mexico Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 108: Mexico Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 109: Argentina Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 110: Argentina Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 111: Argentina Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 112: Chile Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 113: Chile Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 114: Chile Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 115: Colombia Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 116: Colombia Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 117: Colombia Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 118: Rest of LATAM Byler Disease Market Size and Forecast By Disease Type - 2022-2034 (USD USD Billion)

Table 119: Rest of LATAM Byler Disease Market Size and Forecast By Treatment Type - 2022-2034 (USD USD Billion)

Table 120: Rest of LATAM Byler Disease Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

We are featured on: